CREATE CANCER AND OTHER DISEASES AND THEN CASH ON -- by Dr. Leo Rebello

May 23, 2008

Shantaram Shenai sent me the following from the Times of India of 21st May 2008 (page 23).

PROFIT PILL Cancer drug market to touch $48bn in 2008 Rupali Mukherjee | TNN

The global oncology market (anti-cancer drugs) - growing the fastest among all therapies, is expected to touch $48 billion this year, fuelled by higher drug spending in emerging economies including India.

Pharmaceutical spending in countries such as India, Mexico and Turkey will grow by 12% over the next 15 years, compared with single-digit growth for more developed nations, estimates research consultancy IMS.

Sale of cancer drugs will grow at nearly double the rate of global pharma market and reach $80 billion by 2012. The overall pharma market is expected to grow at a little over 6%.

Advent and introduction of new treatments, an increasing number of patients on chemotherapy in major markets and evidence that more people in emerging markets are gaining access to modern targeted therapies will contribute to sales of cancer drugs growing at a compound rate of 12 to 15%, industry experts say.

In India, the oncology market is $225 million (Rs 900 crore), and is expected to reach $850 million (Rs 3,350 crore) by 2012, growing with a CAGR of nearly 30%.

"With the incidence of cancer cases rising in India, companies have realized the potential that this segment has to offer. Approximately 30 companies operate in oncology segment like Biocon, Ranbaxy, Cipla, Dr Reddy's, Sun Pharma, Nicholas Piramal, AstraZeneca are already here with a slew of drugs" says Sujay Shetty associate director (life sciences), PricewaterhouseCoopers India.

To get a toe-hold in the growing market, Ranbaxy has entered into a partnership with Zenotech for oncology products. In US, Ranbaxy-Zenotech has successfully filed seven generic injectable ANDAs (abbreviated new drug applications) for products with combined market share of over $2 billion (at innovator prices). In India, Zenotech has introduced a speciality oncology product for treatment of renal cell carcinoma (kidney cancer).

With upwards of 3.5 million cases as estimated prevalence in India and with one million plus new cases diagnosed every year, the scourge of cancer is a tremendous disease burden. Cancer of the head and neck among males and that of the cervix and breast among females are leading the tables in terms of the key tumor types.

They create the disease and then cash on it. Read below what E McBean PhD has to say in his eye opening book, The Poisoned Needle : Dr. Leo Rebello

"Cancer was practically unknown until smallpox vaccination began .. I have had to deal with 200 cases of cancer and I never saw a case of cancer in an unvaccinated cancer." Dr. W B Clark, New York Press Jan 1909

"... 80 percent of these cancer deaths are caused by the ... vaccinations they have undergone." Dr H Snow, London Cancer Hospital

"I have removed cancers from vaccinated arms exactly where the poison was injected." Dr E J Post Berimont, Michigan.

"The chief, if not the sole cause of the monstrous increase in cancer has been vaccination." Dr R Bell, British Cancer Hospital.